Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Benjamin

Showing results (551-560 of 632) with videos related to

Pageof 64
Sort By:
Protein Engineering, Design & Selection : PEDS|January 26, 2018
Engineered cysteine antibodies: an improved antibody-drug conjugate platform with a novel mechanism of drug-linker stabilityD Sussman, L Westendorf, D W Meyer, et al.
Neuroimage|September 18, 2012
A left cerebellar pathway mediates language in prematurely-born young adultsR Todd Constable, Betty R Vohr, Dustin Scheinost, et al.
Cancer|September 15, 1990
The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemiaW G Woods, F B Ruymann, B C Lampkin, et al.
Patient Education and Counseling|March 8, 2000
Missed opportunities to impact fast response to AMI symptomsJ G Zapka, J M Oakes, D G Simons-Morton, et al.
Journal of Medicinal Chemistry|February 11, 2017
Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R)Vivek Kumar, Amy E Moritz, Thomas M Keck, et al.
Journal of Inherited Metabolic Disease|April 24, 2009
The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell linesE R Benjamin, J J Flanagan, A Schilling, et al.
Cancer Research|February 28, 2016
Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical ModelsFu Li, Kim K Emmerton, Mechthild Jonas, et al.
Biotechnology for Biofuels|September 22, 2018
Engineering xylose metabolism in thraustochytrid T18Alexandra Merkx-Jacques, Holly Rasmussen, Denise M Muise, et al.
The American Surgeon|May 4, 2023
Blunt Traumatic Abdominal Wall Hernias: An Indicator for Emergent Laparotomy?Adora T Santos, Olivia Jagiella-Lodise, Phillip Kim, et al.
Epigenetics|January 21, 2017
Potential epigenetic biomarkers of obesity-related insulin resistance in human whole-bloodSamantha E Day, Richard L Coletta, Joon Young Kim, et al.
Pageof 64

Showing results (551-560 of 632) with videos related to

Sort By:
Pageof 64
Protein Engineering, Design & Selection : PEDS|January 26, 2018
Engineered cysteine antibodies: an improved antibody-drug conjugate platform with a novel mechanism of drug-linker stabilityD Sussman, L Westendorf, D W Meyer, et al.
Neuroimage|September 18, 2012
A left cerebellar pathway mediates language in prematurely-born young adultsR Todd Constable, Betty R Vohr, Dustin Scheinost, et al.
Cancer|September 15, 1990
The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemiaW G Woods, F B Ruymann, B C Lampkin, et al.
Patient Education and Counseling|March 8, 2000
Missed opportunities to impact fast response to AMI symptomsJ G Zapka, J M Oakes, D G Simons-Morton, et al.
Journal of Medicinal Chemistry|February 11, 2017
Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R)Vivek Kumar, Amy E Moritz, Thomas M Keck, et al.
Journal of Inherited Metabolic Disease|April 24, 2009
The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell linesE R Benjamin, J J Flanagan, A Schilling, et al.
Cancer Research|February 28, 2016
Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical ModelsFu Li, Kim K Emmerton, Mechthild Jonas, et al.
Biotechnology for Biofuels|September 22, 2018
Engineering xylose metabolism in thraustochytrid T18Alexandra Merkx-Jacques, Holly Rasmussen, Denise M Muise, et al.
The American Surgeon|May 4, 2023
Blunt Traumatic Abdominal Wall Hernias: An Indicator for Emergent Laparotomy?Adora T Santos, Olivia Jagiella-Lodise, Phillip Kim, et al.
Epigenetics|January 21, 2017
Potential epigenetic biomarkers of obesity-related insulin resistance in human whole-bloodSamantha E Day, Richard L Coletta, Joon Young Kim, et al.
Pageof 64